Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older?
about
Impact of the 2009 US Preventive Services Task Force guidelines on screening mammography rates on women in their 40sDistinguishing screening from diagnostic mammograms using Medicare claims data.Validation of colonoscopic findings from a structured endoscopic documentation database against manually collected medical records data.Disparities in preventive procedures: comparisons of self-report and Medicare claims data.Effect of cost-sharing reductions on preventive service use among Medicare fee-for-service beneficiaries.Evolution of breast cancer screening in the Medicare population: clinical and economic implications.Estimating screening test utilization using electronic health records dataAssessing the impact of a cooperative group trial on breast cancer care in the medicare population.Accuracy of Medicare claims for identifying findings and procedures performed during colonoscopyMammography Screening Among the Elderly: A Research Challenge.Evaluating surveillance breast imaging and biopsy in older breast cancer survivors.Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?Heterogeneity in mammography use across the nation: separating evidence of disparities from the disproportionate effects of geography.The cost of breast cancer screening in the Medicare population.Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision AnalysesGeographic access and the use of screening mammography.Risk of advanced-stage breast cancer among older women with comorbiditiesPractices that reduce the Latina survival disparity after breast cancer.Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography.Racial and ethnic differences in use of mammography between Medicare Advantage and traditional Medicare.Diagnostic ionizing radiation exposure in a population-based sample of children with inflammatory bowel diseases.Medicare beneficiaries more likely to receive appropriate ambulatory services in HMOs than in traditional medicare.Mammography utilization among Black and White Medicare beneficiaries in high breast cancer mortality US counties.Breast cancer screening, area deprivation, and later-stage breast cancer in Appalachia: does geography matter?Time from Screening Mammography to Biopsy and from Biopsy to Breast Cancer Treatment among Black and White, Women Medicare Beneficiaries Not Participating in a Health Maintenance Organization.Challenges With Identifying Indication for Examination in Breast Imaging as a Key Clinical Attribute in Practice, Research, and Policy.Comorbidities and mammography use interact to explain racial/ethnic disparities in breast cancer stage at diagnosis.Utilization and predictors of early repeat colonoscopy in Medicare beneficiaries.Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing?
P2860
Q28657905-08ECE530-6C0C-47DC-A23B-0B58937AC89CQ30559155-87CBFE11-E0F7-455C-9F4D-A748085DC8E3Q30980312-1E48A5DF-8808-4994-9580-7005D34F15B8Q31063147-0DB69595-4907-4F3D-BAB3-9A47119D46A4Q33551547-77705E6D-98D6-4E9D-A2EB-ACA62D765C13Q34137696-36B4FAA6-F052-487B-B39F-8F93D39475CFQ35136606-B2AA9EBF-E59D-4A9F-8B65-DF4070335F14Q36058251-15B340C9-0CF3-4ACA-A542-BE22E031C747Q36097656-6A1CF23A-FF41-417E-9E8A-443F79DC5485Q36315547-72D848EE-98F5-490A-BAFF-337B29D8CF43Q36336744-042E7670-6117-4832-B89A-231C789FD9AEQ36659650-588844BC-54F8-4CD6-9E87-889E10CBFD34Q36775571-50C072E2-B088-4F57-83F9-952C8A500EE4Q36802201-CB024B86-2A42-4CDE-8C51-C64613B546F8Q36808978-89256CA0-C5C2-4148-BE97-7069A723D6ADQ36824934-8C6B78DA-E706-4A10-A0E8-9BCE54B17E8EQ37062924-E1E31A3D-DF5B-47FB-9856-83549F7368C5Q37286964-13C7BB1E-629A-4567-A3C0-E5542258E922Q37396964-655D3DF5-8E06-4937-8075-280915EF0B56Q37399341-51190AC0-8B27-4167-B59C-9855E844C7F3Q37458514-13051F6E-07E6-4B3F-BC1F-2E7F34236C1FQ37586179-9D15FE80-1E8A-421E-BDF7-812A22200202Q37639750-D2F9A798-5F5A-4331-BB46-95AA74F0D0F0Q37685510-7D772682-340E-49E4-9AAE-77F747EC20EEQ39257286-317FAB2C-449A-414D-A7A1-65A7B04ACF8EQ39288226-38CB03D9-0844-4EC7-AB25-327EBB299C9BQ43464198-AD56A141-3D92-4334-8F43-3E6475F602C1Q50542611-4B18607E-B833-494D-A676-38AC51B1EE61Q51554509-6A1E21BF-4B4E-4921-B2BD-08D2E0DF2A5E
P2860
Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older?
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Can Medicare billing claims da ...... among women ages 65 and older?
@ast
Can Medicare billing claims da ...... among women ages 65 and older?
@en
type
label
Can Medicare billing claims da ...... among women ages 65 and older?
@ast
Can Medicare billing claims da ...... among women ages 65 and older?
@en
prefLabel
Can Medicare billing claims da ...... among women ages 65 and older?
@ast
Can Medicare billing claims da ...... among women ages 65 and older?
@en
P2093
P1433
P1476
Can Medicare billing claims da ...... among women ages 65 and older?
@en
P2093
Chris Quale
Karla Kerlikowske
Philip W Chu
Robert Rosenberg
P304
P356
10.1097/01.MLR.0000207436.07513.79
P577
2006-05-01T00:00:00Z